Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1007/s10067-020-05190-5 http://scihub22266oqcxt.onion/10.1007/s10067-020-05190-5 32474885!7260446!32474885     free     free     free Deprecated: Implicit conversion from float 209.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 209.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 209.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 209.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 209.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 209.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 243.2 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Clin+Rheumatol 2020 ; 39 (7): 2085-2094 Nephropedia Template TP {{tp|p=32474885|t=2020. Cytokine storm in COVID-19: pathogenesis and overview of anti-inflammatory agents used in treatment |pdf=|usr=}}{{32474885}} gab.com Text Cytokine storm in COVID-19: pathogenesis and overview of anti-inflammatory agents used in treatment JO: Clin Rheumatol http://www.kidney.de/pget.php?&tw=1&pmid=32474885 #FOAvip COVID-19 infection has a heterogenous disease course; it may be asymptomatic or causes only mild symptoms in the majority of the cases, while immunologic complications such as macrophage activation syndrome also known as secondary hemophagocytic lymphohistiocytosis, resulting in cytokine storm syndrome and acute respiratory distress syndrome, may also occur in some patients. According to current literature, impairment of SARS-CoV-2 clearance due to genetic and viral features, lower levels of interferons, increased neutrophil extracellular traps, and increased pyroptosis and probable other unknown mechanisms create a background for severe disease course complicated by macrophage activation syndrome and cytokine storm. Various genetic mutations may also constitute a risk factor for severe disease course and occurrence of cytokine storm in COVID-19. Once, immunologic complications like cytokine storm occur, anti-viral treatment alone is not enough and should be combined with appropriate anti-inflammatory treatment. Anti-rheumatic drugs, which are tried for managing immunologic complications of COVID-19 infection, will also be discussed including chloroquine, hydroxychloroquine, JAK inhibitors, IL-6 inhibitors, IL-1 inhibitors, anti-TNF-alpha agents, corticosteroids, intravenous immunoglobulin (IVIG), and colchicine. Early recognition and appropriate treatment of immunologic complications will decrease the morbidity and mortality in COVID-19 infection, which requires the collaboration of infectious disease, lung, and intensive care unit specialists with other experts such as immunologists, rheumatologists, and hematologists. Twit Text FOAVip Cytokine storm in COVID-19: pathogenesis and overview of anti-inflammatory agents used in treatment ????Clin Rheumatol http://www.kidney.de/pget.php?&tw=1&pmid=32474885 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=32474885 #FOAvip English Wikipedia <ref>{{Cite pmid|32474885}}</ref> Cytokine storm in COVID-19: pathogenesis and overview of anti-inflammatory agents used in treatment #MMPMID32474885 Soy M; Keser G; Atagunduz P; Tabak F; Atagunduz I; Kayhan S Clin Rheumatol 2020[Jul]; 39 (7): 2085-2094 PMID32474885show ga COVID-19 infection has a heterogenous disease course; it may be asymptomatic or causes only mild symptoms in the majority of the cases, while immunologic complications such as macrophage activation syndrome also known as secondary hemophagocytic lymphohistiocytosis, resulting in cytokine storm syndrome and acute respiratory distress syndrome, may also occur in some patients. According to current literature, impairment of SARS-CoV-2 clearance due to genetic and viral features, lower levels of interferons, increased neutrophil extracellular traps, and increased pyroptosis and probable other unknown mechanisms create a background for severe disease course complicated by macrophage activation syndrome and cytokine storm. Various genetic mutations may also constitute a risk factor for severe disease course and occurrence of cytokine storm in COVID-19. Once, immunologic complications like cytokine storm occur, anti-viral treatment alone is not enough and should be combined with appropriate anti-inflammatory treatment. Anti-rheumatic drugs, which are tried for managing immunologic complications of COVID-19 infection, will also be discussed including chloroquine, hydroxychloroquine, JAK inhibitors, IL-6 inhibitors, IL-1 inhibitors, anti-TNF-alpha agents, corticosteroids, intravenous immunoglobulin (IVIG), and colchicine. Early recognition and appropriate treatment of immunologic complications will decrease the morbidity and mortality in COVID-19 infection, which requires the collaboration of infectious disease, lung, and intensive care unit specialists with other experts such as immunologists, rheumatologists, and hematologists. |*Antirheumatic Agents/classification/immunology/pharmacology[MESH] |*Coronavirus Infections/complications/drug therapy/immunology[MESH] |*Cytokine Release Syndrome/etiology/immunology/therapy[MESH] |*Lymphohistiocytosis, Hemophagocytic/etiology/immunology/therapy[MESH] |*Macrophage Activation Syndrome/etiology/immunology/therapy[MESH] |*Pandemics[MESH] |*Pneumonia, Viral/complications/drug therapy/immunology[MESH] |Betacoronavirus/isolation & purification[MESH] |COVID-19[MESH] |Humans[MESH] |Patient Selection[MESH] |SARS-CoV-2[MESH]Cytokine storm in COVID-19: pathogenesis and overview of anti-inflamma(epmc).pdf DeepDyve Pubget Overpricing